Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (71-80 of 411) with videos related to

Pageof 42
Sort By:
Life Sciences|May 19, 2006
Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicityZhizhong Ma, Xing Wei, Christine Fontanilla, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|May 13, 2008
Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease?Georg Juckel, Frauke Clotz, Thomas Frodl, et al.
Psychopharmacology|June 13, 2006
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trialStefan J Teipel, Alexander Drzezga, Peter Bartenstein, et al.
Molecular Neurodegeneration|October 8, 2011
Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's diseaseHong Jiang, Harald Hampel, David Prvulovic, et al.
CNS Drugs|April 8, 2006
Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's diseasePeter Johannsen, Eric Salmon, Harald Hampel, et al.
The Medical Clinics of North America|May 7, 2013
Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer diseaseStefan J Teipel, Michel Grothe, Simone Lista, et al.
Neuroscience Letters|March 5, 2003
Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's diseasePeter Schönknecht, Johannes Pantel, Aoife Hunt, et al.
The European Journal of Neuroscience|July 26, 2011
Common capacity-limited neural mechanisms of selective attention and spatial working memory encodingFabian Fusser, David E J Linden, Benjamin Rahm, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Biomarkers in Sporadic and Familial Alzheimer's DiseaseSimone Lista, Sid E O'Bryant, Kaj Blennow, et al.
Experimental Gerontology|October 27, 2009
Total and phosphorylated tau protein as biological markers of Alzheimer's diseaseHarald Hampel, Kaj Blennow, Leslie M Shaw, et al.
Pageof 42

Showing results (71-80 of 411) with videos related to

Sort By:
Pageof 42
Life Sciences|May 19, 2006
Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicityZhizhong Ma, Xing Wei, Christine Fontanilla, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|May 13, 2008
Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease?Georg Juckel, Frauke Clotz, Thomas Frodl, et al.
Psychopharmacology|June 13, 2006
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trialStefan J Teipel, Alexander Drzezga, Peter Bartenstein, et al.
Molecular Neurodegeneration|October 8, 2011
Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's diseaseHong Jiang, Harald Hampel, David Prvulovic, et al.
CNS Drugs|April 8, 2006
Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's diseasePeter Johannsen, Eric Salmon, Harald Hampel, et al.
The Medical Clinics of North America|May 7, 2013
Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer diseaseStefan J Teipel, Michel Grothe, Simone Lista, et al.
Neuroscience Letters|March 5, 2003
Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's diseasePeter Schönknecht, Johannes Pantel, Aoife Hunt, et al.
The European Journal of Neuroscience|July 26, 2011
Common capacity-limited neural mechanisms of selective attention and spatial working memory encodingFabian Fusser, David E J Linden, Benjamin Rahm, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Biomarkers in Sporadic and Familial Alzheimer's DiseaseSimone Lista, Sid E O'Bryant, Kaj Blennow, et al.
Experimental Gerontology|October 27, 2009
Total and phosphorylated tau protein as biological markers of Alzheimer's diseaseHarald Hampel, Kaj Blennow, Leslie M Shaw, et al.
Pageof 42